FDA granted clearance for Hugo's Instrument Exit Point, while CAS was expected to grow mid-to-high teens.
1 report, 1 independent
Updated Aug 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA granted clearance for Hugo's Instrument Exit Point, while CAS was expected to grow mid-to-high teens.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Medtronic plc
medical device company
Nothing else this week.
- FDA